Furthermore, EFNA5 promotes the malignant progression of pancreatic cancer [47] but played a tumor suppressor role in glioma by inhibiting EGFR [48], tumor invasiveness, and metastasis in hepatoma and colorectal cancer [49, 50]. Here, EFNA5 is linked to pancreatic neoplasm.